Copyright West LLC. Minimum 15 minutes delayed.

Investors & Media

Press Releases

Date Title and Summary Additional Formats
Toggle Summary Dicerna Pharmaceuticals and Ipsen Enter into an Exclusive Research Collaboration for the Development of New Therapeutic Agents in Endocrinology and Oncology View HTML
Toggle Summary Dicerna Signs Research Collaboration and License Agreement for Drug Delivery Systems and Dicer Substrate siRNA (DsiRNA) Pharmaceuticals with Kyowa Hakko Kirin View HTML
Toggle Summary Dicerna Pharmaceuticals to Present at 2009 Biologics Drug Delivery & Beyond Conference View HTML
Toggle Summary Dicerna Pharmaceuticals to Present at Upcoming Conferences View HTML
Toggle Summary Dicerna Pharmaceuticals Scientific Founder To Present Data Demonstrating Dual Inhibitory Function of Aptamer-Dicer Substrate siRNA Conjugates at Oligonucleotide Therapeutics Conference View HTML
Toggle Summary Archemix and Dicerna to Collaborate on Conjugated Aptamer-Dicer Substrate RNAi Therapeutics View HTML
Toggle Summary Dicerna Pharmaceuticals Announces Appointment of Industry Veteran David Madden as Chairman of the Board View HTML
Toggle Summary Dicerna Pharmaceuticals to Present at Upcoming RNAi-Focused Scientific Conferences View HTML
Toggle Summary Dicerna Pharmaceuticals to Present at Upcoming Conferences View HTML
Toggle Summary Dicerna Co-Founder and Scientific Advisory Board Chair Awarded the 2008 Cozzarelli Prize by the Proceeding of the National Academy of Sciences Editorial Board View HTML